{
  "meta": {
    "title": "Calcium_Regulating_Hormones",
    "url": "https://brainandscalpel.vercel.app/calcium-regulating-hormones-fce19eec.html",
    "scrapedAt": "2025-11-30T11:19:55.959Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Parathyroid hormone</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">1,25 DHCC</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcitonin</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following hormones primarily increases calcium absorption from the intestine?</span></p>",
      "unique_key": "DT1320800",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320800,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>1,25-DHCC (also called calcitriol), the active form of vitamin D, is the principal hormone responsible for promoting calcium absorption in the intestine.</p>\n<ul>\n<li>It is a steroid hormone synthesised from vitamin D through hydroxylation in the liver (25-hydroxylation) and kidneys (1&alpha;-hydroxylation).</li>\n<li>Acts on intestinal epithelial cells to increase the expression of calcium-binding proteins, enhancing calcium absorption.</li>\n<li>Its synthesis is stimulated by parathyroid hormone in response to hypocalcemia.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20251004e9f3ee84-782b-43e6-ac74-9b3b960f3c24.png\">",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperventilation</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Acidosis</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoproteinemia</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">: Which of the following triggers tetany even if calcium level is near normal?</span></p>",
      "unique_key": "DT1320836",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320836,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><br /> <strong>Explanation:</strong><strong> </strong></p>\n<p>Hyperventilation lowers PaCO<sub>2,</sub> causing respiratory alkalosis. The rise in pH increases the binding of calcium to plasma proteins, especially albumin, reducing free (ionised) Ca<sup>2</sup><sup>+</sup>, which is the physiologically active form, thus precipitating tetany despite normal total serum calcium levels.</p>\n<ul>\n<li>Tetany is a state of hyperexcitability of peripheral nerves and muscles due to low extracellular ionised calcium.</li>\n  <li>Ca<sup>2</sup><sup>+</sup> stabilises the voltage-gated sodium channels. Low ionised Ca<sup>2</sup><sup>+</sup> lowers the threshold for nerve excitation, making them fire spontaneously.</li>\n  <li>Clinically evident tetany generally occurs when ionised Ca<sup>2</sup><sup>+</sup> drops below 1 mmol/L.</li>\n</ul>\n<p><strong>Clinical Features of Tetany:</strong></p>\n<ul>\n<li>Perioral numbness, tingling</li>\n<li>Muscle cramps and spasms</li>\n<li>Carpopedal spasm</li>\n<li>Laryngospasm (in severe cases)</li>\n</ul>\n<p><strong>Clinical Signs:</strong></p>\n<ul>\n<li><strong>Chvostek's Sign: </strong>Tapping the facial nerve at the angle of the jaw produces twitching of the ipsilateral facial muscles due to increased neuromuscular excitability.</li>\n<li>Trousseau's Sign: Inflating a BP cuff above systolic pressure for 3 minutes induces carpopedal spasm, indicative of latent tetany.</li>\n</ul>\n<p><strong>Management :</strong></p>\n<ul>\n<li>Immediate treatment includes IV calcium gluconate to restore ionised calcium levels.</li>\n<li>Address the underlying cause (e.g., stop hyperventilation, correct hypocalcemia or alkalosis).</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Acidosis (Option B):</strong> Acidosis increases ionised calcium by reducing calcium binding to albumin. So, it does not precipitate tetany.</p>\n<p><strong>Hypoproteinemia (Option C):</strong> Hypoproteinemia decreases total calcium but doesn't significantly affect ionised calcium; hence, tetany is unlikely.</p>",
      "correct_choice_id": 11,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">It increases blood calcium and phosphorus level</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">It increases blood calcium but decrease phosphorus level</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">It decreases blood calcium level but does not affect phosphorus level</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">It decreases blood calcium and phosphorus level</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is true about calcitriol hormone?</span></p>",
      "unique_key": "DT1320837",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320837,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Calcitriol (1,25-dihydroxycholecalciferol), the active form of vitamin D, increases both calcium and phosphate absorption from the intestine, thereby raising their levels in blood.</p>\n<p><strong>Physiological Role of Calcitriol :</strong></p>\n<ul>\n<li>Calcitriol is synthesised by a two-step hydroxylation of vitamin D: first in the liver (25-hydroxylation) and then in the kidney (1-hydroxylation).</li>\n<li>Intestinal action:<br /> Enhances expression and insertion of NaPi-IIb cotransporters on enterocytes to increase phosphate absorption.<br />  &bull; Stimulates calbindin synthesis and epithelial calcium channels (TRPV6), promoting intestinal calcium absorption.</li>\n<li>Renal action:<br /> Promotes phosphate reabsorption (though to a lesser extent compared to PTH's opposing action).</li>\n<li>Skeletal action:<br /> Indirectly promotes bone mineralisation by maintaining adequate plasma calcium and phosphate levels.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>It increases blood calcium but decreases phosphorus level (Option B):</strong> Calcitriol increases both calcium and phosphate levels.</p>\n<p><strong>It decreases blood calcium level but does not affect phosphorus level (Option C):</strong> Calcitriol does not decrease calcium; it increases calcium by enhancing intestinal absorption.</p>\n<p><strong>It decreases the blood calcium and phosphorus levels (Option D):</strong> It raises, not lowers, both calcium and phosphate levels in plasma.</p>",
      "correct_choice_id": 21,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">PMCA1b</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">NCX1</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">TRPV6</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Calbindin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the protein marked '?' in the figure that helps in calcium absorption from intestine<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20251004f9c7bcb0-01ce-4513-ba77-f745b05f058e.png\"></span></p>",
      "unique_key": "DT1320838",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320838,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>TRPV6 (Transient Receptor Potential Vanilloid type 6) is the primary apical membrane calcium channel in intestinal epithelial cells that facilitates calcium entry from the intestinal lumen into the enterocyte.</p>\n<p><strong>Mechanism of Intestinal Calcium Absorption:</strong></p>\n<ul>\n<li><strong>Apical Entry: </strong>\n<ul>\n<li><strong>TRPV6</strong> allows passive calcium entry into enterocytes across the apical membrane.</li>\n</ul>\n</li>\n<li><strong>Intracellular Transport:</strong>\n<ul>\n<li><strong>Calbindin-D9k</strong>, a calcium-binding protein, buffers cytosolic calcium and facilitates its diffusion toward the basolateral side. <strong>(Option D ruled out)</strong></li>\n</ul>\n</li>\n<li><strong>Basolateral Exit:</strong>\n<ul>\n<li><strong>PMCA1b</strong> (Plasma Membrane Ca&sup2;<sup>+</sup>-ATPase) actively pumps calcium out of the cell using ATP. <strong>(Option A ruled out)</strong></li>\n  <li><strong>NCX1</strong> (Na<sup>+</sup>/Ca<sup>2</sup><sup>+</sup> exchanger) facilitates the exchange of intracellular calcium with extracellular sodium ions. <strong>(Option B ruled out)</strong></li>\n</ul>\n</li>\n</ul>",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">NaPi-IIa</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">NaPi-IIb</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">NaPi-IIc</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Sodium-dependent phosphate transporters are present in the tubules of the kidney. Which of the following is powerfully inhibited by PTH hormone?</span></p>",
      "unique_key": "DT1320839",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320839,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Parathyroid hormone (PTH) powerfully inhibits phosphate reabsorption in the proximal renal tubule by specifically targeting the NaPi-IIa cotransporter, which is the major transporter involved in renal phosphate reabsorption.</p>\n<ul>\n<li>NaPi-IIa is abundantly expressed in the apical membrane of proximal tubule cells.</li>\n<li>PTH induces its internalisation and degradation, thereby decreasing phosphate reabsorption and promoting phosphaturia.</li>\n<li>This regulatory effect of PTH is crucial for preventing hyperphosphatemia during conditions of elevated bone resorption.</li>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20251003897067c1-3219-4bc3-a24e-83add3ee3072.PNG\">\n</ul>\n<p><strong>Actions of PTH:</strong></p>\n<ul>\n<li>Increases serum calcium by:\n<ul>\n<li>Stimulating bone resorption (increasing osteoclast activity)</li>\n<li>Enhancing renal Ca&sup2;<sup>+</sup> reabsorption</li>\n<li>Promoting calcitriol synthesis (increasing intestinal Ca&sup2;<sup>+</sup>  absorption)</li>\n</ul>\n</li>\n<li>Decreases serum phosphate by:\n<ul>\n<li>Inhibiting NaPi-IIa, reducing phosphate reabsorption in proximal tubule</li>\n</ul>\n</li>\n</ul>",
      "correct_choice_id": 41,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">TRPV6 in intestinal cells</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">TRPV5 in proximal tubules</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Ca+2ATPase in the intestine</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Among the following, which is/are the target of action for 1,25 1,25-dihydroxycholecalciferol?</span></p>",
      "unique_key": "DT1320840",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320840,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>1,25-dihydroxycholecalciferol (active vitamin D or calcitriol) binds to intracellular vitamin D receptors and modulates gene transcription, enhancing calcium absorption and reabsorption across several tissues.</p>\n<p>In intestinal epithelial cells, it:</p>\n<ul>\n<li>Increases expression of TRPV6, a calcium channel at the apical membrane, promoting Ca&sup2;<sup>+</sup> entry. <strong>(Option A)</strong></li>\n<li>Upregulates Ca&sup2;<sup>+</sup>-ATPase (PMCA1b) on the basolateral membrane, facilitating active calcium extrusion into blood. <strong>(Option B)</strong></li>\n<li>Enhances calbindin-D9k levels, which binds with intracellular calcium and help shuttle it across the enterocyte.</li>\n</ul>\n<p>In renal tubular cells (especially the distal nephron), calcitriol:</p>\n<ul>\n<li>Increases TRPV5 expression, enhancing calcium reabsorption at the apical side. <strong>(Option C)</strong></li>\n<li>Indirectly supports the action of PTH in conserving calcium.</li>\n</ul>\n<p>In bone, calcitriol acts on osteoblasts to modulate expression of RANKL and osteocalcin, indirectly regulating osteoclast differentiation and activity.</p>",
      "correct_choice_id": 54,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Inadequate intake of vitamin D</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Type I vitamin D-resistant rickets</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Type II vitamin D-resistant rickets</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">None of above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 6-year-old boy was diagnosed with rickets when his parents visited the paediatrician for bowlegs. The doctor prescribed the boy 1,25-dihydroxycholecalciferol supplements, but he does not respond to it. Probable diagnosis is</span></p>",
      "unique_key": "DT1320841",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320841,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Type II vitamin D - resistant rickets is due to end-organ resistance to 1,25-dihydroxycholecalciferol, explaining the lack of response despite adequate supplementation.</p>\n<p><strong>Vitamin D deficiency</strong> is the most common cause of rickets, usually due to poor sunlight exposure or low dietary intake. These children respond well to either vitamin D or 1,25-dihydroxycholecalciferol.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20251003b7054db8-08a6-43b0-adc6-4ab15136487f.PNG\">\n<p>It often presents with <strong>hypocalcemia, hypophosphatemia, elevated PTH</strong>, and features of rickets <strong>despite normal or elevated 1,25(OH)<sub>2</sub>D levels</strong>.</p>",
      "correct_choice_id": 63,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Bone pain</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypercalcemia</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal stone</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperkalemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 37-year-old patient visited the doctor for some symptoms. The doctor evaluated the patient and found that the patient has primary hyperparathyroidism. Which of the following is least likely to be associated symptom in this patient?</span></p>",
      "unique_key": "DT1320843",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320843,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Parathyroid hormone (PTH) does not regulate potassium balance, so hyperkalemia is not typically associated with primary hyperparathyroidism.</p>\n<p><strong>Physiology of Primary Hyperparathyroidism</strong>:</p>\n<ul>\n<li>Primary hyperparathyroidism results from autonomous overproduction of PTH by the parathyroid glands.</li>\n<li>Elevated PTH leads to:\n<ul>\n<li>Increased osteoclastic bone resorption - bone pain, osteoporosis, fractures.</li>\n<li>Increased renal reabsorption of calcium - hypercalcemia.</li>\n<li>Decreased renal phosphate reabsorption - hypophosphatemia.</li>\n<li>Increased activation of vitamin D enhanced intestinal calcium absorption.</li>\n<li>Nephrolithiasis due to high urinary calcium levels.</li>\n</ul>\n</li>\n</ul>\n<p><strong>(Other options ruled out)</strong></p>\n<p><strong>Clinical Features:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250820c5ca0bfa-dc60-4497-9a57-89bf9f919bae.png\">",
      "correct_choice_id": 74,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteoporosis</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypocalciuric hypercalcemia</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoparathyroidism</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 33-year-old male presents with persistently elevated serum calcium levels but normal or slightly raised PTH. Urinary calcium levels are unusually low despite hypercalcemia. Which of the following is the most likely explanation?</span></p>",
      "unique_key": "DT1320844",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320844,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>A mutation in the calcium-sensing receptor (CaSR) gene impairs feedback inhibition of PTH secretion, leading to hypocalciuric hypercalcemia.</p>\n<ul>\n<li>The calcium-sensing receptor (CaSR) is a G-protein-coupled receptor located on parathyroid cells and renal tubular cells.</li>\n<li>It monitors extracellular calcium levels and regulates PTH secretion through negative feedback.</li>\n<li>Loss-of-function mutation in CaSR reduces the sensitivity to calcium, so even when plasma calcium is high, the gland doesn&rsquo;t suppress PTH adequately.</li>\n<li>This leads to:\n<ul>\n<li>Mild to moderate hypercalcemia</li>\n<li>Inappropriately normal or slightly elevated PTH</li>\n<li>Low urinary calcium excretion &rarr; 'hypocalciuric hypercalcemia'</li>\n</ul>\n</li>\n<li>The condition is typically familial (FHH) and benign.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Osteoporosis (Option A): </strong>Not a direct feature of CaSR mutation. Although calcium regulation is disrupted, PTH levels are not high enough to cause significant bone resorption, typical of osteoporosis.</p>\n<p><strong>Hypoparathyroidism (Option C):</strong> In CaSR mutations, PTH is not suppressed&mdash;it may be normal or even elevated. Hypoparathyroidism is defined by low PTH, usually from gland destruction or autoimmunity.</p>",
      "correct_choice_id": 82,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcitonin</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Parathyroid hormone</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcitriol</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following hormones does not affect the plasma phosphate level in the blood?</span></p>",
      "unique_key": "DT1320845",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320845,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Calcitonin lowers blood calcium but has minimal or no direct effect on plasma phosphate regulation.</p>\n<p><strong>Phosphate Regulation - Hormonal Roles:</strong></p>\n<ul>\n<li>Parathyroid hormone (PTH): <strong>(Option B ruled out)</strong>\n<ul>\n<li>Strongly reduces plasma phosphate by decreasing phosphate reabsorption in proximal renal tubules.</li>\n<li>This occurs via internalisation of NaPi-IIa cotransporters.</li>\n</ul>\n</li>\n<li>Calcitriol (1,25-dihydroxycholecalciferol): <strong>(Option C ruled out)</strong>\n<ul>\n<li>Increases phosphate absorption from the intestine.</li>\n<li>Acts by increasing NaPi-IIb expression on enterocyte apical membranes.</li>\n</ul>\n</li>\n<li>Calcitonin:\n<ul>\n<li>Acts mainly on calcium by inhibiting osteoclastic bone resorption.</li>\n<li>Has no major effect on phosphate homeostasis in humans.</li>\n</ul>\n</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250820c5fdc8e5-5c13-4e1f-ac18-7302b4e445f2.png\">",
      "correct_choice_id": 91,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibition osteoclast activity</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Estrogen receptor modulator</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">PTH analogue</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">None of above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old postmenopausal woman was diagnosed with postmenopausal osteoporosis. She was given etidronate. What is the mechanism of action?</span></p>",
      "unique_key": "DT1320846",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320846,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Etidronate is a bisphosphonate that inhibits bone resorption by directly suppressing osteoclast function.</p>\n<p><strong>Mechanism of Action of Etidronate:</strong></p>\n<ul>\n<li>Etidronate belongs to the bisphosphonate class of drugs.</li>\n<li>It binds strongly to hydroxyapatite crystals in bone.</li>\n<li>When osteoclasts resorb bone, they internalise the bisphosphonate.</li>\n<li>This leads to osteoclast apoptosis or inactivation, reducing bone resorption.</li>\n<li>Ultimately, this increases bone mineral density and reduces fracture risk in osteoporosis.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025082095bc7397-5aa7-4c2f-afd5-2199b4ca274c.png\">\n<p><strong>Osteoclasts:</strong></p>\n<ul>\n<li>Osteoclasts are multinucleated cells derived from the monocyte/macrophage lineage.</li>\n<li>They attach to bone surfaces and form resorption pits by secreting hydrogen ions (via proton pumps) and proteolytic enzymes.</li>\n<li>This acidic microenvironment dissolves hydroxyapatite, releasing calcium and phosphate into circulation.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250820e9d432eb-5211-4d54-a96f-b048d966ee52.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Estrogen receptor modulator (Option B): </strong>Raloxifene is a SERM that mimics estrogen&rsquo;s positive effects on bone but is not a bisphosphonate.<br /> <strong>PTH analogue (Option C): </strong>Teriparatide is a recombinant PTH fragment that stimulates bone formation, unlike etidronate, which inhibits resorption.</p>",
      "correct_choice_id": 101,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}